Maureen Richey | Healthcare Moderator
Trilingual moderator, ethnographer and workshop facilitator (English, Spanish and Portuguese)
Expert in use of digital, ethnographic and traditional market research approaches to generate insight (virtual and in-person IDIs, dyads/triads, focus groups, home interviews, shop-alongs, intercepts, online communities, traditional, digital and mobile ethnography)
Led qualitative market research studies HCPs, payers, industry leaders, patients, caregivers and consumers in 20+ countries
Expertise in brand marketing (identity, strategy, positioning, messaging, creative campaign and ad testing), commercial strategy (value prop, TPP and opportunity assessments, competitive landscaping, brand launch planning), and buying process (e.g., insight mining, customer journey, drivers and barriers)
Broad and deep therapeutic area knowledge, including oncology and rare disease
Extensive experience with US and Ex-US healthcare systems and payer/market access models
BA in Molecular & Cell Biology from the University of California at Berkeley. MBA from the UCLA Anderson School of Management
Stakeholders (not exhaustive)
MDs: Addiction, allergists, anesthesiologists, cardiologists (clinical, surgical, interventional), diabetologists, dermatologists (medical/cosmetic), endocrinologists, ENT, epileptologists, ER/critical care, fertility, gastroenterologists, hematologists, hepatologists, hospitalists, hospice/palliative, infectious disease, internal medicine, KOLs (various specialties), movement disorder, MS specialists, neurologists, nuclear medicine, nephrologists, OB-GYNs, oncologists (medical, surgical, interventional), ophthalmologists, optometrists, orthopedic and sports medicine, pain medicine, pathologists, pediatricians, plastic surgeons, primary care (PCPs, FPs, GPs), psychiatrists, pulmonologists, radiologists, rheumatologists, surgeons (general, transplant, vascular, etc.), toxicologists, urologists
Other HCPs: Dieticians, genetic counselors, LCPs, nurses (LNs, RNs, NPs, PAs, NNs), office managers, pharmacists (retail, specialty, hospital, LTC), techs (pharmacy, cath lab, dialysis), veterinarians (small and large animal, equine)
Patients, Caregivers & Consumers (adults, teens, kids)
Payers: US medical and pharmacy directors of major national and regional MCOs, PBMs and IDNs. Variety of payer types in Canada, EU and LATAM, including those representing public and private sectors with national, regional and hospital responsibilities
Other: LTC managers (assisted living, retirement community and skilled nursing home, etc.), social workers, psychologists, counselors, biologic coordinators, billing specialists, IT admin, sales reps, MSLs, client internal stakeholders, US criminal justice system stakeholders (judges, probation officers, correctional officers, etc.), employer-side health benefits administrators, health benefit consultants and brokers
Therapy Areas (not exhaustive)
Addiction; Allergy (immune therapy, allergic rhinitis); Anesthesiology (vitals monitoring, nerve blocks); Cardiology (AHF, atrial fibrillation, CHF, HTN, interventional cardiology–stents, angioplasty, endografts, long QT, Mi, OACs, OAPs, stroke); Consumer OTC (e.g. cold, flu, cough, analgesics, allergy, dry eyes, supplements, meal replacements); Medical & Cosmetic Dermatology (rosacea, acne, eczema, dermal fillers, neurotoxin); Diagnostics (genetic and biomarker testing); Gastroenterology (IBS, IBD/UC/CD, SBS, Celiac, fistula); Hematology (anemia, hemophilia and other bleeding disorders, sickle cell, thrombosis, cancers); Hepatology (AASLD, Alpha-1, hepatitis, cirrhosis, NASH, transplant); Imaging (various modalities, e.g. MRI, CT, PET, SPECT); Immunology / Infectious Disease (ABSSSI, C. diff, hepatitis, HIV/AIDS, Lyme, MRSA, PID, PrEP, STIs, transplant suppression); Mental Health (ADHD, bipolar, depression, eating disorders, PTSD, schizophrenia); Metabolic Disorders (dyslipidemia, diabetes type 1 and 2, obesity, CGMs); Neurology (Alzheimer’s/dementia/MCI, epilepsy/LGS/DS, migraine, Parkinson’s, stroke, TBI), Neuromuscular (ALS, CIDP, GBS, MG, MMN, MS, TD, IVIG/SCIG); Oncology / Hematologic Oncology (breast – HER+/-, TN, ovarian, lung – NSCLC, SCLC, pancreas, prostate, liver – HCC, renal – RCC, melanoma, leukemias / lymphomas – ALL, CML, CLL/SLL, DLBCL, FL, MM, MCL, MF); Optometry / Ophthalmology (dry eye, wet AMD, diabetic macular edema, glaucoma, presbyopia); Orthopedics & Sports Medicine (OA, arthroplasties); Pain Management; Plastic Surgery (breast, eyelid, liposuction, tummy tuck, rhinoplasty); Rare Diseases (e.g. cystic fibrosis, hemophilia, VWD, EPI, Long QT, lysosomal storage disorders –Gaucher, Hunter, Fabry); Renal (CKD, SHPT); Respiratory (asthma, allergic rhinitis, COPD, PAH, cystic fibrosis); Rheumatology (RA, gout, lupus/SLE, PsO/PsA, Sjogren’s, vasculitis); Sleep Medicine (sleep apnea, narcolepsy, idiopathic hypersomnia, insomnia, sleep wearables); Urology (OAB); Vaccines (COVID, Hep A, Hep B, HPV, flu, meningococcal, pneumococcal, JE, shingles, vaccine adjuvants); Women’s Health (contraception, IVF, endometriosis, uterine fibroids)
Sample Studies
Future treatment landscape for HER2+ breast cancer (US)
Scientific messaging and positioning for a novel therapy for triple negative breast cancer (US, EU5)
Payer messaging to inform global value dossier for novel therapy in multiple myeloma (US, CAN, EU5)
Pancreatic cancer patient journey (US, EU5). Patient journey, competitive landscaping and opportunity assessment in ES-NSCLC and LS-SCLC (US)
Opportunity assessment and ad board facilitation for novel NSCLC treatment (US, EU and LATAM)
KOL research and HCP messaging / sales aid testing for Crohn’s and ulcerative colitis biologic (US, Canada)
Patient journey (incl. smart phone ethnography and short film) for HIV high-risk populations (US)
Dosing, administration and device design research injectable HIV treatment (US)
Opportunity assessment for LAIs for people with schizophrenia in the criminal justice system (US)
Drivers and barriers to treatment of severe hemophilia in emerging markets (Mexico, Turkey, India)
Patient journey in ALS (Canada)
Guideline adherence research in Parkinson’s (US, EU5)
DTC ad concept testing for a cystic fibrosis therapy (US)
IVF patient journey (Canada, Brazil, Germany)
Patient journey in PsO and PsA (US, EU5, Brazil)
Market landscaping and communications campaign research for a dermal filler portfolio (US, Canada)
Eczema patient journey with IDIs, focus groups, video diaries and a short film (UK)
TV ad testing for a rosacea Rx treatment (US)
Payer research on positioning of biosimilar portfolio (US, CAN, EU5, Brazil)
Drivers and barriers research in Wet AMD (US)
Positioning research for a novel AAA stent graft (US)